|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.12 USD | -0.08% |
|
+3.36% | -15.19% |
| 06-24 | AlphaValue/Baader Europe Reduces EPS Estimates for Genmab on Merger Financing Costs | MT |
| 06-23 | Genmab: Financing weighs now, pipeline pays later |  |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENMAB A/S | Bio Therapeutic Drugs | -0.08% | +3.36% | -15.19% | +27.41% | -37.96% | 15.94B |
-
|
-
|
-
|
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
- Charts Genmab A/S
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
